532606 Sigma-Aldrich5-Lipoxygenase Inhibitor, MK591 - CAS 147030-01-1 - Calbiochem
MK591; MK0591; 5-LOX inhibitor, 5- Lipoxygenase inhibitor, FLAP
More>> MK591; MK0591; 5-LOX inhibitor, 5- Lipoxygenase inhibitor, FLAP Less<<Synonyms: FLAP Inhibitor, MK591, sodium 3-(3-(tert-butylthio)-1-(4-chlorobenzyl)-5-(quinolin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropanoate, L-686,708, MK-0591
Recommended Products
Overview
Replacement Information |
---|
Key Spec Table
CAS # | Empirical Formula |
---|---|
147030-01-1 | C₃₄H₃₄ClN₂NaO₃S |
Pricing & Availability
Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
---|---|---|---|---|---|---|
5.32606.0001 |
|
Glass bottle | 5 mg |
|
— |
Product Information | |
---|---|
CAS number | 147030-01-1 |
Form | White solid |
Hill Formula | C₃₄H₃₄ClN₂NaO₃S |
Chemical formula | C₃₄H₃₄ClN₂NaO₃S |
Reversible | Y |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | FLAP |
Primary Target IC<sub>50</sub> | 3.1 nM |
Purity | ≥98% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | Y |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalogue Number | GTIN |
5.32606.0001 | 04055977240948 |
Documentation
5-Lipoxygenase Inhibitor, MK591 - CAS 147030-01-1 - Calbiochem SDS
Title |
---|
References
Reference overview |
---|
Chu, J., et al. 2012. J. Neuroinflamm. 9, 127. Sarveswaran, S., et al. 2011. Bioch. Biophy. Acta. 1813, 2108. Sarveswaran, S., et al. 2010. Cancer Lett. 291, 167. Uematsu, T., et al. 1995. Br. J. Clin. Pharm. 40, 59. |
Brochure
Title |
---|
NPI Flyer- Epigenetics and Nuclear Function Feature |
New Products - Antibodies, Small Molecule, Inhibitors |
Technical Info
Title |
---|
White Paper: Further considerations of antibody validation and usage. |